The SITC Cancer Immunotherapy Guidelines - Multiple Myeloma Webinar, held on September 3, 2020, is available for continuing education credits.
Continuing Education Credit Information
Continuing Education Credits are available for physicians, nurses and pharmacists. To view full accreditation information, click here.
- Click the Register Now button.
- You will be prompted to log in or create a free account.
- Click the Request Credit button.
- On the Manage Your Credit screen, follow the instructions to select the Credit Reporting Organization you wish to claim credit for. (Note: For pharmacist completers, enter your NABP# (required).) Then click Continue.
- Complete the evaluation. Then click Submit.
- On the Confirm All Information screen, verify your Credit Reporting Organization and click Process Credit.
- On the Education Credit Profile Screen, scroll down to the Submitted Credit section to view your certificate.
For Pharmacists: Pharmacists have up to 30 days to complete the online evaluation and claim credit for participation so that information can be submitted to the CPE Monitor as required.
This activity is intended for healthcare providers who treat cancer patients, including oncologists, physicians, disease specialists, registered nurses, nurse practitioners, pharmacists and physician assistants engaged in care of patients with multiple myeloma.
Webinar Learning Objectives
- Outline appropriate use of immunotherapies in multiple myeloma according to clinical guidelines.
- Identify and manage side effects from immunotherapy treatments for multiple myeloma.
- Describe investigational therapies for multiple myeloma, including bispecifics, cellular therapies and antibody-drug conjugates.
- Ajai Chari, MD – Icahn School of Medicine at Mount Sinai
- Adam Cohen, MD – Abramson Cancer Center at the University of Pennsylvania
- Nina Shah, MD – University of California San Francisco Medical Center
The recorded webinar video and slides will be available here within 24 hours after the webinar concludes.
(Please note that the on-demand webinars are not available for continuing education credits.)
Jointly provided by Postgraduate Institute for Medicine and the Society for Immunotherapy of Cancer.
This webinar is supported, in part, by independent medical education grants from Amgen, AstraZeneca Pharmaceuticals LP, Celgene Corporation and Merck & Co., Inc.